Dr. Jonathan Shepherd serves as a bioinformatics scientist. He joined GeneCentric Therapeutics in 2022 after serving as a Research Associate at the Lineberger Comprehensive Cancer Center at the University of North Carolina where he studied prognostic and predictive features associated with triple-negative breast cancer and the role of the tumor-immune-microenvironment. Dr. Shepherd received his PhD in Molecular and Cellular Biology from Baylor College of Medicine.